Check Point
CHKP Β· Systems Software
$159.03
οΏ½οΏ½UiPath
PATH Β· Systems Software
$14.13
1.4%The short version
- Check Point is the larger business, with $2.7B of revenue in fiscal 2025 against $1.6B for UiPath, about 1.7 times as much.
- UiPath grew revenue faster (12.7%, against 6.3%).
- Check Point kept more of each dollar of sales as operating profit (30.5% operating margin, against 3.5% operating margin).
- Check Point turned more of its sales into free cash flow (43.0% FCF margin, against 21.9% FCF margin).
| Latest fiscal year | CHKP Β· FY25 | PATH Β· FY26 |
|---|---|---|
| Size | ||
| Market cap | $17.5B | $7.4B |
| Revenue | $2.7B | $1.6B |
| Free cash flow | $1.2B | $352M |
| Net income | $1.1B | $282M |
| Growth | ||
| Revenue growth | 6.3% | 12.7% |
| 5-year growth | 5.7% | 21.5% |
| Share count change | β3.1% | β2.7% |
| Profitability | ||
| Gross margin | 86.7% | 83.2% |
| Operating margin | 30.5% | 3.5% |
| Net margin | 38.8% | 17.5% |
| FCF margin | 43.0% | 21.9% |
| Return on capital | β | 13.7% |
| Return on equity | 37.3% | 14.4% |
| Balance sheet | ||
| Net debt | β$2.4B | β$1.5B |
| Net debt / EBITDA | β2.8x | β20.0x |
| Dividends and buybacks | $1.4B | $329M |
| Valuation & quality | ||
| P/E | β | 21.1x |
| Piotroski F-score | 7 | 7 |
FY17
CHKP $1.9B
PATH β
FY18
CHKP $1.9B
PATH β
FY19
CHKP $2.0B
PATH β
FY20
CHKP $2.1B
PATH $336M
FY21
CHKP $2.2B
PATH $608M
FY22
CHKP $2.3B
PATH $892M
FY23
CHKP $2.4B
PATH $1.1B
FY24
CHKP $2.6B
PATH $1.3B
FY25
CHKP $2.7B
PATH $1.4B
FY26
CHKP β
PATH $1.6B
CHKP
PATH
FY17
CHKP 49.8%
PATH β
FY18
CHKP 47.7%
PATH β
FY19
CHKP 44.2%
PATH β
FY20
CHKP 43.8%
PATH β153.9%
FY21
CHKP 41.9%
PATH β18.2%
FY22
CHKP 38.0%
PATH β56.1%
FY23
CHKP 37.2%
PATH β32.9%
FY24
CHKP 34.2%
PATH β12.6%
FY25
CHKP 30.5%
PATH β11.4%
FY26
CHKP β
PATH 3.5%
CHKP
PATH
FY17
CHKP $1.1B
PATH β
FY18
CHKP $1.1B
PATH β
FY19
CHKP $1.1B
PATH β
FY20
CHKP $1.1B
PATH β$375M
FY21
CHKP $1.2B
PATH $27.2M
FY22
CHKP $1.1B
PATH β$63.8M
FY23
CHKP $1.0B
PATH β$33.8M
FY24
CHKP $1.0B
PATH $292M
FY25
CHKP $1.2B
PATH $306M
FY26
CHKP β
PATH $352M
CHKP
PATH
FY17
CHKP β
PATH β
FY18
CHKP β
PATH β
FY19
CHKP β
PATH β
FY20
CHKP β
PATH β
FY21
CHKP β
PATH β
FY22
CHKP β
PATH β
FY23
CHKP β
PATH β
FY24
CHKP β
PATH β
FY25
CHKP β
PATH β
FY26
CHKP β
PATH 13.7%
CHKP
PATH
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.